| |
|

December 2021 Vol. 9 No.12
Other viewing option
Abstract
Full text
Reprint (PDF) (101 KB)
Search Pubmed for articles by:
Fakhar
N
Tariq
M
Other links:
PubMed Citation
Related articles in PubMed
|
|
Merit Research Journal of Medicine and Medical
Sciences (ISSN: 2354-323X) Vol. 9(12) pp.
429-433,
December, 2021
Copyright © 2021 Author(s) retain the copyright
of this article
DOI: 10.5281/zenodo.5802348 |
|
Original Research Article
Comparison of the mean
total loss of mydriasis with topical ketorolac tromethamine 0.5%
and nepafenac 0.1% during phacoemulsification |
|
| |
| |
|
Fakhar Un Nisa1,
Muhammad Ayyub Khan2,
Rashida Riaz3, Samia
Iqbal4*, Madiha
Tariq5 |
|
|
1Consultant Ophthalmologist in Shiekh
Zayed Hospital Lahore
2Assistant Professor Gomal Medical University, Dera
Ismail Khan
3Consultant Ophthalmologist, Ophthalmology
Department, Mayo Hospital Lahore
4Optometrist and Lecture, ophthalmology Department
the University of Lahore
5Consultant Ophthalmologist in Al ahsan Trust
Hospital, Lahore
*Corresponding Author's E-mail: samiaiqbal988@gmail.com
Received: 08 August 2021 I Accepted: 23
September 2021 I Published: 24 December 2021 I
Article ID: MRJMMS21073
Copyright © 2021 Author(s) retain the
copyright of this article.
This article is published under the terms of the
Creative Commons Attribution
License 4.0. |
|
|
Abstract |
|
|
Phacoemulsification
with intraocular-lens implantation is the current surgical
treatment of choice for cataract extraction. To prevent
complications during surgery, there should be adequate pupillary
dilation for better visualization of the posterior chamber. The
objective of this study is to compare mean total loss of
mydriasis with topical ketorolac tromethamine 0.5% and nepafenac
0.1% during phacoemulsification. The study design is randomized
controlled trial and it was carried out in Department of
Ophthalmology, Shaikh Zayed Hospital Lahore. The duration for
this process is six months (August 2019 to January 2020). A
total of 100 patients were selected from Ophthalmology Outdoor
of Shaikh Zayed Hospital Lahore. The patients were randomly
divided into two groups by lottery method, 50 patients in group
A (Nepafenac 0.1%) and 50 patients in group B (Ketorolac
tromethamine 0.5%). Five minutes later, tropicamide 0.5%, 1 drop
every 15 minutes for 4 doses were instilled in both treatment
groups. The two groups were compared with diameters of pupil was
measured at different stages of cataract surgery and the mean
values were compared across the two groups. The mean age of the
patients in group A was 55.6±5.6 years and in group B was
54.6±5.7 years. The mean pupil diameter before surgery in group
A was 7.9±0.4 and in group B was 8.0±0.5. The mean pupil
diameter after surgery in group A was 6.4±0.6 and in group B was
5.7±0.5. The mean total loss of mydriasis in group A was 1.4±0.6
and in group B was 2.1±0.4. It is concluded from this study that
Topical nepafenac has been shown to be a more effective
inhibitor of miosis during phacoemulsification and provides a
more stable mydriatic effect throughout the surgical procedure
compared to topical ketorolac.
Keywords: Ketorolac Tromethamine 0.5%, Nepafenac 0.1%,
Phacoemulsification, Total loss of mydriasis
|
|
|
|